Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Assets

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Assets ₹5,881 Cr₹6,840 Cr₹7,115 Cr₹6,709 Cr₹6,425 Cr

What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹5,881 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Assets
Mar2024₹5,881 Cr
Mar2023₹6,840 Cr
Mar2022₹7,115 Cr
Mar2021₹6,709 Cr
Mar2020₹6,425 Cr

How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Assets % Change
Mar2024 ₹5,881 Cr
-14.03
Mar2023 ₹6,840 Cr
-3.86
Mar2022 ₹7,115 Cr
6.04
Mar2021 ₹6,709 Cr
4.42
Mar2020 ₹6,425 Cr -

Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹40,729.9 Cr 1.9% 4.8% 41.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,818.0 Cr -3.3% 3.4% 13.9% Stock Analytics
DIVIS LABORATORIES ₹164,628.0 Cr 4.1% 15.2% 60.2% Stock Analytics
CIPLA ₹120,775.0 Cr 0.6% 5.6% 11.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,758.0 Cr 1.9% 3.7% 28.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,791.0 Cr 6.2% 11.4% 2.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.9%

4.8%

41.7%

SENSEX

0.7%

9.6%

10.7%


You may also like the below Video Courses